NCT00437645 - Efficacy and Safety of Valsartan/Amlodipine Compared to Amlodipine in Patients With Essential Hypertension | Biotech Hunter

Enrollment

1,183

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

November 30, 2007

Study Completion Date

November 30, 2007

Conditions

Essential Hypertension

Interventions

DRUG

Valsartan 160 mg capsules

DRUG

Amlodipine 5 mg capsules

DRUG

placebo

capsules

Trial Locations (12)

sites in Argentina, Agentina

sites in Chile, Chile

sites in Ecuador, Ecuador

sites in Finland, Finland

sites in France, France

sites in Germany, Germany

sites in Italy, Italy

sites in Norway, Norway

sites in Spain, Spain

sites in Sweden, Sweden

sites in Switzerland, Switzerland

sites in Turkey, Turkey